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Adenosine triphosphate (ATP) and its metabolite adenosine regu-
late airway mucociliary clearance via activation of purinoceptors. In
this study, we investigated the contribution of goblet cells to airway
epithelial ATP release. Primary human bronchial epithelial (HBE)
cultures, typically dominated by ciliated cells, were induced to
developgoblet cell metaplasia by infection with respiratory syncytial
virus (RSV) or treatment with IL-13. Under resting conditions,
goblet-cell metaplastic cultures displayed enhanced mucin secretion
accompanied by increased rates of ATP release and mucosal surface
adenosine accumulation as compared with nonmetaplastic control
HBEcultures. Intracellular calciumchelation [1,2-bis(o-aminophenoxy)-
ethane-N,N,N9,N9-tetraacetic acid tetraacetoxymethyl ester] or
disruption of the secretory pathways (nocodazole, brefeldin A, and
N-ethylmaleimide) decreased mucin secretion and ATP release in
goblet-cell metaplastic HBE cultures. Conversely, stimuli that trig-
gered calcium-regulated mucin secretion (e.g., ionomycin or UTP)
increased luminal ATP release and adenyl purine accumulation in
control and goblet-cell metaplastic HBE cultures. Goblet cell–
associated ATP release was not blocked by the connexin/pannexin
hemichannel inhibitor carbenoxolone, suggesting direct nucleotide
release from goblet cell vesicles rather than the hemichannel in-
sertion. Collectively, our data demonstrate that nucleotide release
is increased by goblet cell metaplasia, reflecting, at least in part,
a mechanism tightly associated with goblet cell mucin secretion. In-
creased goblet cell nucleotide release and resultant adenosine accumu-
lation provide compensatory mechanisms to hydrate mucins by
paracrinestimulationofciliatedcell ionandwatersecretionandmaintain
mucociliary clearance, and to modulate inflammatory responses.
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Mucociliary clearance (MCC), a critical component of innate
lung defense mediated by airway epithelia, requires coordina-
tion of airway surface liquid (ASL) hydration, ciliary beat, and
mucin secretion. ATP and its metabolite adenosine are coordi-
nators of these functions (1). ATP, released from airway epithelia
to ASL, and adenosine activate epithelial cell surface P2Y2 and
A2B purinoceptors, respectively, and regulate ion transport,
maintain ASL hydration, and promote ciliary beat. The ATP-
gated P2X4 receptor has also been proposed to regulate ion
transport in airway epithelia (2, 3). In addition, ATP promotes
mucin secretion via P2Y2 receptors expressed on goblet cells (1).
Airway epithelia are comprised of several different cell
types, including basal, ciliated, and goblet cells. A crucial
question in airway surface homeostasis is how goblet cells,
which secrete mucins ‘‘dry’’ (i.e., without concurrent water
secretion) (4), communicate with neighboring ciliated cells to
secrete sufficient liquid for mucin hydration and maintenance of
MCC. We hypothesize that goblet cells secrete ATP with
mucins to signal to ciliated cells in a paracrine fashion, thus
promoting ASL volume secretion. Indeed, previous studies
illustrated that mucin granules of a goblet-like human airway
epithelial Calu-3 cell line contain nucleotides (5) and that
nucleotides are released from Calu-3 cells concomitantly with
mucins (6). However, it is unknown whether nucleotide release
is coordinated with mucin secretion in airway epithelia in vivo.
Well differentiated primary human bronchial epithelial
(HBE) cell cultures simulate in vivo airway epithelia morpho-
logically and physiologically. To test the hypothesis that airway
epithelial goblet cells release ATP in association with mucins,
well differentiated primary HBE cell cultures, typically domi-
nated by ciliated cells, were studied under basal conditions and
after maneuvers designed to produce goblet cell metaplasia.
The first maneuver included infection of cultures with respira-
tory syncytial virus (RSV), a common respiratory pathogen
among young children and elderly subjects with respiratory
complications (e.g., chronic obstructive pulmonary disease).
RSV induced massive goblet cell metaplasia in primary HBE
cultures several weeks after infection. Second, goblet cell
metaplasia was induced by IL-13, as previously described (7,
8). In each model, the links between mucin secretion and
nucleotide release were tested under resting conditions and




Primary HBE cultures were established from surgical specimens of
main stem or lobar bronchi from healthy donors on Transwell supports
(Corning, Lowell, MA) and maintained in an air–liquid interface (9).
Use of the cells was approved by the University of North Carolina
Institutional Review Boards.
CLINICAL RELEVANCE
This is the first study to demonstrate that goblet cells are
important contributors of enhanced nucleotides and nucle-
osides in airway lumen during goblet cell metaplasia. Our
data have relevance to a score of airway diseases charac-
terized by goblet cell metaplasia, such as viral infection,
asthma, and chronic obstructive pulmonary disease, by
suggesting that increased goblet cell nucleotide release
and the resultant adenosine accumulation provide com-
pensatory mechanisms to hydrate mucins by paracrine
stimulation of ciliated cell ion and water secretion and to
modulate inflammatory responses.
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RSV Infection of Cultures
Well differentiated HBE cultures were infected with a recombinant
RSV expressing green fluorescent protein (GFP) (rgRSV) (10).
RgRSV is similar to the parent wild-type RSV with respect to rep-
lication, tropism, and pathogenicity (10). RgRSV inactivated by UV
light was used as a mock control. Viral infections were monitored by
GFP expression in virus-infected cells. Cultures were studied at 3, 14,
and 42 days after RSV infection.
IL-13 Treatment of Cultures
Well differentiated HBE cultures were treated with 10 ng/ml IL-13
(PeproTech, Rocky Hill, NJ) serosally for 5 days. ALI medium (made
in house [9]) containing IL-13 was freshly prepared and replaced at
each 48-hour time point. Cultures were studied at the end of the IL-13
treatment.
Cytokine Measurements
Twenty-four hours after fresh ALI medium (9) was added to the
serosal side of cultures, serosal samples were collected for IL-8
measurements by ELISA (R&D Systems, Minneapolis, MN) (11).
ATP Measurements
ATP release was measured in real time using soluble luciferin (150 mM)
(BD Biosciences, San Jose, CA) and luciferase (0.5 mg/culture) (Sigma,
St. Louis, MO) in a Turner TD-20/20 luminometer (Turner Biosystems,
Sunnyvale, CA) (12).
Measurements of Adenyl Purines
Cultures were rinsed bilaterally and preincubated for 2 hours with 300 ml
mucosal Hanks’ balanced salt solution. Mucosal samples were collected
(100 ml), and ATP, adenosine diphosphate (ADP), adenosine mono-
phosphate (AMP), and adenosine concentrations were measured by
etheno-derivatization and HPLC analysis (13). In some experiments,
UTP (100 mM) or ionomycin (5 mM) was added to the mucosal fluid 10
minutes before sample collection.
Measurement of Uridine Diphosphate Glucose
Cells were preincubated for 15 minutes mucosally with Hanks’
balanced salt solution containing b,g-methylene ATP (300 mM).
Mucosal samples were collected (200 ml), and uridine diphosphate
(UDP)-glucose was measured by HPLC analysis (17).
Mucin Secretion Measurements
Mucin secretion was measured by slot blot analysis or ELISA of the
mucosal fluid (6, 14). The UNC-230 rabbit polyclonal anti-mucin
common subunit antibody was used as a primary antibody in slot blots
and ELISA to quantitate total polymeric mucins of all subtypes (14, 15).
Scoring of Goblet Cell Numbers
Immunohistochemistry was performed on the whole-mounted Trans-
wells to differentially stain mucin-containing cells (by periodic acid-
Schiff ) and ciliated cells (by monoclonal antitubulin antibody [Sigma])
(16). Horizontal (X-Y) dual images with differential interference
contrast (to visualize cellular outlines) and laser (to visualize immu-
nohistochemical signals) were obtained by laser confocal microscopy
(LSM 510; Carl Zeiss, Oberkochen, Germany) for quantitation of
goblet and nongoblet cell numbers.
Statistical Analysis
Data were expressed as mean values 6 SE. Where appropriate, data were
analyzed by Student’s t test or ANOVA with GraphPad InStat software
(GraphPad, La Jolla, CA). Statistical significance was defined as P , 0.05.
RESULTS
Enhanced Mucin Secretion, ATP Release, and Adenosine
Accumulation in RSV-Induced Goblet-Cell
Metaplastic Cultures
Well differentiated cultures of normal HBE cells are dominated
by ciliated cells (typically z90%), which are specifically suscep-
tible to RSV infection (10). After HBE cultures were exposed to
a recombinant, GFP-bearing RSV (rgRSV), the number of
infected cells, as indicated by GFP-associated fluorescence, was
maximal at 3 days after infection and waned over 42 days (Figure
1A) (10). Airway epithelial inflammation, as measured by IL-8,
was also maximal at 3 days after RSV infection and waned in
parallel with the decrease in the number of virus-positive cells
(Figure 1B). An increase in histologically defined goblet cell
numbers was observed at 14 days after RSV infection (Figure
1C). Goblet cell numbers continued to increase at 42 days after
infection, approaching approximately 50% of the cells, with
a concomitant decrease in ciliated cell numbers, as quantitated
by tubulin–periodic acid-Schiff staining (Figure 1D).
Consistent with the increase in goblet cell numbers, an
increase in mucin release from resting cultures was detected
at 42 days after RSV infection (Figure 1E). Mucosal ATP
concentrations were not different between RSV- and mock-
infected HBE cultures at any time point as measured by real-
time luminometry or etheno-derivatization (z1–5 nM) (Figure
1F). However, enhanced concentrations of AMP, adenosine,
and total adenyl purine species were observed in RSV, as
compared with mock-infected cultures, at 42 days after infection
(Figure 1F). These results are consistent with the notion that
goblet-cell metaplastic cultures exhibit increased release of
ATP, ADP, and AMP (5) and that these nucleotides are rapidly
metabolized to AMP or adenosine by ecto-ATPases (5, 12, 18,
19).
We examined the extent to which increased AMP and
adenosine concentrations associated with goblet cell metaplasia
reflected an increase in ATP release and ecto-hydrolysis at the
cell surface. When cell surface ecto-ATPases were inhibited by
the addition of ecto-ATPase inhibitors (b,g-methylele-ATP,
ebselen, and levamisole) to the luminal cell surface (Figure 2A)
(12), ATP accumulated over time in ASL at similar rates in
RSV- and mock-infected cultures at 3 and 14 days after
infection (Figure 2B). However, the ATP accumulation rates
from RSV-infected cultures increased up to approximately 3-
fold as compared with mock-infected cultures at 42 days after
infection (Figures 2A and 2B). ATP release rates were pro-
portional to the increase in goblet cell numbers over the time
course of RSV infection (Figure 2C).
Enhanced ATP Release from IL-13–Induced Goblet-Cell
Metaplastic Cultures
Viral infection can trigger cellular responses additional to
goblet cell metaplasia, which may also contribute to the ob-
served increment in nucleotide release. Thus, a ‘‘sterile’’ model
(i.e., IL-13–induced goblet cell metaplasia) was used to in-
dependently validate the results illustrated above. After IL-13
treatment of HBE cultures for 5 days, an increase in goblet cell
numbers (Figures 3A and 3B) was accompanied by increased
mucin secretion (Figure 3C), increased adenosine and total
adenyl purine accumulation in ASL (Figure 3D), and increased
ATP release rates (Figure 3E). ATP release rates were pro-
portional to goblet cell numbers (Figure 3F).
Pharmacologic Inhibition of Vesicular Release under
Basal Condition
Because goblet cell mucin granule secretion involves Ca21–
regulated exocytosis (20), we tested the effect of the Ca21
chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic
acid tetraacetoxymethyl ester (BAPTA-AM) on mucin secre-
tion and ATP release rates. BAPTA-AM inhibited mucin
secretion in control (non–goblet-cell metaplastic) cultures and,
to a greater extent, in RSV- or IL-13–treated goblet-cell
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metaplastic cultures (Figure 4A). ATP release rates were also
inhibited by BAPTA-AM in control cultures and, to a greater
extent, in goblet-cell metaplastic cultures (Figure 4B). Agents
that disrupt the secretory pathway (e.g., nocodazole, which dis-
rupts microtubules; brefeldin A, which dissembles the Golgi
complex; and N-ethylmaleimide, which inhibits docking of
secretory granules to plasma membrane) also inhibited mucin
secretion in goblet-cell metaplastic cultures (Figure 4C). The
effects of these inhibitors were not significant over sample
variability in nonmetaplastic control cultures (Figure 4C).
ATP release rates in response to each reagent mirrored the
pattern of mucin secretion, that is secretory pathway inhibitors
were effective in inhibiting ATP release in goblet-cell meta-
plastic, but not in control, cultures (Figure 4D).
Increased Nucleotide Release Coupled to Stimulated
Mucin Secretion
To further investigate the relationship between rates of mucin
secretion and nucleotide release, we measured nucleotide re-
lease under conditions of agonist-promoted, Ca21–regulated
mucin granule secretion (21). As predicted on the basis of
previous studies, apical treatment of control HBE cultures with
UTP or ionomycin for 10 minutes resulted in increased secre-
tion of mucins (Figure 5A) (6, 22–25). Mucin secretion in
response to these agonists was markedly enhanced in RSV
and IL-13–induced goblet-cell metaplastic cultures (Figure 5A).
As observed with mucin secretion, UTP and ionomycin
treatment increased AMP, adenosine, and total adenyl purine
concentrations in ASL in control (non–goblet-cell metaplastic)
Figure 1. Time course of respiratory syncytial virus
(RSV) infection, RSV-induced goblet cell metaplasia,
and extracellular adenyl purine profiles. The data were
obtained at 3, 14, and 42 days after RSV (or mock)
infection. (A) Top: Live intracellular RSV intensity visu-
alized by green fluorescent protein fluorescence of the
recombinant virus (rgRSV). Bar, 30 mm. Bottom: Quan-
titation of green fluorescent protein fluorescence in-
tensity (by Image J). (B) IL-8 levels in serosal medium.
(C ) Representative x-z sectioned histological pictures
(Richardson staining) of primary human bronchial
epithelial cultures at 14 days after mock (left) or RSV
(right) infection. Bar, 10 mm. (D) Percentages of mucus-
producing cells (goblet cells) quantitated in laser con-
focal microscopy images of differential immunostaining
for ciliated cells (red; tubulin) and goblet cells (green;
periodic acid-Schiff ) overlayed with differential inter-
ference contrast images. (E ) Mucin secretion rates in
control and RSV-induced goblet-cell metaplastic cul-
tures as measured by ELISA over 12 hours. Mucosal
surfaces were washed, and cultures were rested for 24
hours. At t 5 0, 3, 6, 9, and 12 hours, 75 ml Dulbecco’s
modified Eagle’s medium was added on cultures
mucosally. Cultures were incubated for 10 minutes at
378C and sampled for ELISA. Mucin secretion rates over
12 hours were calculated from the amount of mucins in
samples at each time point. (F ) Concentrations of
adenyl purines in airway surface liquid sampled from
resting cultures at 42 days after mock (left blocks) or
RSV (right blocks) infection, as analyzed by etheno-
derivatization. *Significant difference (P , 0.05) over
mock-infected control cultures. Values are mean 6 SE
of four Transwells/subject established from three dif-
ferent subjects.
Figure 2. ATP release rates from cultures after RSV in-
fection. (A) ATP accumulation in airway surface liquid
when epithelial cell surface-mediated ATP hydrolysis was
inhibited by the addition of ecto-ATPase inhibitors (b,
g-methylene-ATP [300 mM], ebselen [30 mM], and leva-
misole [10 mM]) to airway surface liquid at t 5 0. Open
circles and solid circles indicate mock- and RSV-infected
cultures, respectively, at 42 days after infection. (B) ATP
release rates in resting cultures at 3, 14, and 42 days after
RSV (or mock) infection, as measured from ATP accumu-
lation rates by using the method depicted in Fig. 2A and
Ref. 12. (C ) Correlation between goblet cell percentages
(data imported from Fig. 1D) and ATP release rates (data
imported from Fig. 2B). *Significant difference (P , 0.05)
over mock-infected control cultures. Values are mean 6
SE of four Transwells/subject established from three
different subjects.
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cultures (Figure 5B), consistent with a robust increase in ATP/
ADP/AMP release rates with rapid hydrolysis to metabolic
products. In goblet-cell metaplastic (RSV or IL-13–induced)
cultures, UTP and ionomycin treatment produced large in-
creases in adenyl purine concentrations, including ATP and
ADP, consistent with greatly increased rates of nucleotide
release (Figure 5B). The patterns of increased release rates
triggered by ionomycin or UTP were similar between mucin
(Figure 5A) nucleotides/nucleosides (Figure 5B) in all cultures.
The increase in nucleotide release in response to stimuli was
proportional to goblet cell number and the increase in mucin
secretion.
UDP-Glucose Release Rates Correlate Mucin Granule
Release Rates
UDP-glucose is a sugar nucleotide that is a natural agonist for
the P2Y14 receptor. Recent reports indicated that UDP-glucose
Figure 3. Goblet cell metaplasia after IL-13 treatment.
(A) Representative images of differential immunohisto-
chemistry for ciliated cells (red; tubulin) and goblet cells
(green; periodic acid-Schiff ) after 5 days of treatment
with vehicle (left) or IL-13 (right). Bar, 30 mm. (B) Goblet
cell percentages in vehicle- or IL-13–treated cultures
quantitated from the confocal images as represented
in A. (C ) Mucin secretion rates in control and IL-13–
treated goblet-cell metaplastic cultures as measured by
ELISA over 12 hours. (D) Concentrations of adenyl
purines in airway surface liquid sampled from vehicle-
or IL-13–treated cultures under resting condition, as
measured by etheno-derivatization. (E ) ATP release rates
in vehicle- or IL-13–treated cultures. (F ) Correlation
between goblet cell percentages (data imported from
B) and ATP release rates (data imported from E).
*Significant difference (P , 0.05) over vehicle-treated
control cultures. Values are mean 6 SE of three Transwells/
subject established from three different subjects.
Figure 4. ATP and mucin secretion from goblet-cell meta-
plastic cultures. (A and B) Amounts of secreted mucins as
measured by slot blot (A) and ATP release rates (B) in
control, RSV-infected (42 d), or IL-13–treated cultures.
These cultures were treated with BAPTA-AM (100 mM,
30 min) (black bars) or vehicle (white bars) immediately
before the mucin or ATP measurement assays. (C and D)
Amounts of secreted mucins as measured by slot blot (C )
and ATP release rates (D) in control, RSV-infected, or IL-13–
treated cultures. These cultures were treated with secretory
pathway inhibitors: nocodazole (Noco; 20 mM, 4 h),
brefeldin A (BFA) (40 mM, 2.5 h), and N-ethylmaleimide
(NEM) (1 mM, 15 min) or vehicle immediately before the
mucin or ATP measurement assays. For slot blots (A and C ),
300 ml Hanks’ balanced salt solution buffered with 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid was
added to mucosal culture surface, and 100 ml was sampled
15 minutes later. Signal intensity in slot blots was
expressed as relative to that of mock-infected cultures
without inhibitor treatment. *Significant difference (P ,
0.05) between vehicle and the reagent treatment.
†Significant difference (P , 0.05) over nonmetaplastic
control subjects under the same reagent treatment. Values
are mean 6 SE of four Transwells/subject established from
three different subjects.
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is contained in Golgi-derived vesicles and released via an
exocytotic mechanism (26, 27). Indeed, UDP-glucose has re-
cently been shown to be released concomitantly with mucins
from goblet-like Calu-3 cells, suggesting that the nucleotide–
sugar release may be a marker for vesicular exocytosis of
nucleotides (6). Thus, we investigated whether release of this
nucleotide–sugar is increased in goblet-cell metaplastic cultures,
consistent with the postulated granule-associated release of
mucins and purine nucleotides. UDP-glucose concentrations
in ASL were, in fact, significantly greater in goblet-cell meta-
plastic (RSV or IL-13–induced) cultures than in nonmetaplastic
control HBE cultures (Figure 6).
Inhibition of Hemichannels Does Not Affect ATP Release
from Goblet Cells
Cellular ATP release can occur via vesicular exocytosis or via
conductive (i.e., channel- or transporter-mediated) pathways
(28). Our observation of coordinated release of mucins and
nucleotides suggests the involvement of vesicular secretory
pathways in nucleotide release from goblet cells. However,
our data do not distinguish between nucleotide release via
vesicular pathways and vesicle-mediated insertion of a conduc-
tive pathway into the plasma membrane.
Connexin and pannexin hemichannels have been proposed
to conduct ATP in well differentiated primary HBE cultures
and in A549 lung epithelial cells based on the effect of
pharmacological inhibitors (29). In addition, a recent study
has identified pannexin 1 as a putative ATP release channel in
primary human airway epithelia based on the effect of phar-
macological inhibitors and knock-down experiments (30). In
that study, Ransford and colleagues illustrated that primary
HBE cultures displayed strong immunoreactivity against a
40-kD protein by Western blot using a pannexin 1 antibody
and that ciliated cells in primary HBE cultures and human
tracheal sections exhibited strong immunofluorescence by con-
focal microscopy using the same antibody. The immunofluores-
cence was also apparent, albeit diffuse, in cells that resembled
(in morphology) native goblet cells in human tracheal sections,
raising the possibility that pannexin 1 may contribute to ATP
release from goblet cells.
Therefore, we examined whether connexin and pannexin
hemichannels contribute to ATP release in our model of goblet
cell metaplasia. HBE cultures were treated with carbenoxolone,
a nonselective blocker of connexin and pannexin hemichannels.
Preincubation of HBE cultures with carbenoxolone for 15
minutes at 10 and 100 mM, to inhibit pannexins and connexins,
respectively, did not affect ATP release from control or IL-13–
Figure 5. Enhanced nucleotide release associated with
robust mucin secretion. (A) Mucin secretion after UTP
(100 mM, 10 min) or ionomycin (5 mM, 10 min) treat-
ment in control, RSV-infected (42 d), or IL-13–treated
cultures. (B) Adenyl purine profiles at basal (left), UTP-
treated (middle), or ionomycin-treated (right) conditions
in control, RSV-infected (42 d), or IL-13–treated cultures.
*Significant difference (P , 0.05) over nonmetaplastic
control subjects. †Significant difference (P , 0.05) over
basal values (i.e., without UTP or ionomycin treatment).
Values are mean 6 SE of three Transwells/subject estab-
lished from three different subjects.
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induced goblet-cell metaplastic HBE cultures under resting
conditions (Figure 7A). ATP release under stimulation with
UTP (Figure 7B) or ionomycin (Figure 7C) was also not af-
fected by carbenoxolone in control or IL-13–induced goblet-cell
metaplastic cultures. These observations suggest that connexin
and pannexin hemichannels are not involved in ATP release
that is coupled with mucin secretion.
DISCUSSION
Our study demonstrated an association between goblet cell
metaplasia and increased rates of nucleotide release in a model
relevant to in vivo airway epithelia, primary HBE cultures. Our
data further demonstrated that nucleotide release occurs co-
ordinately with mucin secretion and that goblet cells can be
important contributors to nucleotide and nucleoside concentra-
tions in ASL. Nucleotide release coordinated with mucin se-
cretion enables goblet cells to signal neighboring ciliated cells
via purinoceptors to increase ion and liquid secretion and,
hence, properly hydrate newly released mucins.
Goblet cell metaplasia was induced in primary HBE cultures
via two independent approaches, RSV infection and IL-13
treatment. In both models, ATP release and mucin secretion
rates directly correlated with goblet cell number (Figures 2C
and 3). We also observed that nonstimulated (i.e., ‘‘basal’’)
mucin secretion and ATP release rates were similarly reduced
by an intracellular Ca21 chelator, BAPTA-AM (Figures 4A and
4B). These data suggest that mucin secretion and ATP release
from resting goblet cells are not completely ‘‘constitutive’’ (i.e.,
independent of regulation by second messengers) but likely
consisted of ‘‘constitutive’’ and ‘‘basally Ca21–regulated’’ com-
ponents. We speculate that both processes may reflect basally
regulated rates of granule release as proposed by Davis and
Dickey (20).
ATP release and mucin secretion were similarly inhibited by
reagents that inhibit secretory pathways (e.g., nocodazole,
brefeldin A, and N-ethylmaleimide) in goblet-cell metaplastic
cultures (Figures 4C and 4D). Conversely, agonists that in-
creased mucin exocytosis and secretion (i.e., UTP and ionomy-
cin) (Figure 5A) also increased nucleotide release in control
(non–goblet-cell metaplastic) cultures and to a greater extent in
goblet-cell metaplastic cultures (Figure 5B). The increase in
nucleotide release in response to stimuli was in proportion to
the goblet cell numbers and the increase in mucin secretion.
Because the use of a pharmacological agent could elicit off-
target effects, it is important to confirm the results with several
different agents or methods.
Our recent studies indicate that a nucleotide–sugar UDP-
glucose is secreted concomitantly with mucins from goblet-like
cell lines (6). Thus, although the focus of this study was on the
release of adenine nucleotides that enhance MCC functions, we
investigated a correlation between goblet cell metaplasia and
release of a nucleotide sugar that is known to be secreted via
a vesicular-mediated mechanism (27). Goblet-cell metaplastic
cultures released UDP-glucose at greater rates than nonmeta-
plastic control cultures, strengthening the notion that increased
vesicular-mediated release produced paralleled increases in
mucin and nucleotide sugar concentrations in ASL (Figure 6).
UDP-glucose may modulate airway luminal innate immune
responses, given that its receptor, P2Y14, is expressed in neutro-
phils, lymphocytes, and macrophages (31–33) and that UDP-
glucose has been reported to promote secretion of inflammatory
mediators from lung epithelial cell lines (34).
The simplest hypothesis to account for the association be-
tween nucleotide release and mucin secretion is that nucleotides
and mucins are contained in common granules and are released
when vesicles fuse with the apical membrane. Recent studies
Figure 6. UDP-glucose release from goblet-cell metaplastic cultures.
UDP-glucose concentrations in the sampled airway surface liquid from
control, RSV-infected (42 d), or IL-13–treated cultures. After 2 hours of
incubation with mucosal assay buffer, 300 mM b, g-methylene ATP was
added to airway surface liquid to inhibit UDP-glucose hydrolysis and
was incubated for additional 15 minutes. *Significant difference over
mock-infected cultures (P , 0.05). Values are mean 6 SE of four
Transwells/subject established from two different subjects.
Figure 7. ATP release from human bronchial epithelial
cultures treated with connexin or pannexin hemichannels.
(A) Control and IL-13–treated goblet-cell metaplastic
cultures at resting conditions were preincubated with
carbenoxolone (CBX) of indicated concentrations or ve-
hicle for 15 minutes, and ATP release rates were mea-
sured. (B and C ) After the preincubation with CBX or
vehicle, cultures were stimulated with UTP (100 mM) (B)
or ionomycin (5 mM) (C ), and ATP release rates were
measured. Values are mean 6 SE of three Transwells/
subject established from three different subjects.
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have supported this hypothesis by demonstrating that subapical
granules of goblet-like cell lines contain mucins and a spectrum
of adenyl nucleotides (5) and are apically secreted via Ca21–
regulated exocytosis, producing simultaneous mucin secretion
and nucleotide release (6). The increased concentrations of
a range of adenyl purine species on airway surfaces with goblet
cell metaplasia (Figure 5B) could reflect selective release of ATP
from mucin granules with extensive ecto-ATP metabolism.
Conversely, predictions from mathematical models (18) and data
from isolated mucin granules from the Calu-3 lung epithelial cell
line (5) suggest that granules exocytotically release a spectrum of
adenyl nucleotides (ATP, ADP, and AMP).
An alternative hypothesis is that ATP release channels could
be expressed in the mucin granule membrane and inserted into
the plasma membrane during granule exocytosis. However,
carbenoxolone, an inhibitor of the primary candidate for ATP
release channels in airway epithelia (i.e., connexin and pannexin
hemichannels) (29, 30), failed to affect basal or stimulated ATP
release from control or goblet-cell metaplastic cultures (Figure
7). Thus, it is unlikely that ATP release from airway epithelial
goblet cells is predominantly mediated by vesicular insertion of
connexin and pannexin ATP-releasing hemichannels.
Primary HBE cultures, reflecting in vivo airway morphology,
are dominated by ciliated cells (z90%) under normal condi-
tions. Data that ATP release rates (in the absence of shear
stress) correlated with the number of mucus-producing cells
(Figures 2C and 3F) illustrate that mucus cells are a major
contributor to ATP release under such conditions. Data that
HBE cultures with 10 and 70% goblet cells released 0.3 and
1.2 pmol/cm2/min of ATP, respectively (Figure 2C), suggest
that, if the correlation between the percentage of goblet cells
and ATP release rates is linear, cultures with 0 and 100% goblet
cells would release 0.15 and 1.65 pmol/cm2/min of ATP, re-
spectively. Thus, it is estimated that goblet cells contributed to
ATP release approximately 11 times more than ciliated cells
under resting conditions.
On the other hand, airway cells in vivo are constantly
exposed to shear stress (e.g., from breathing and coughing).
Mechanisms of ATP release and contributions of ciliated versus
goblet cells to ATP release under shear stress are likely to be
different from those in the absence of shear stress. A previous
study demonstrated that shear stress caused an approximately
30-fold increase in ATP release as compared with resting
conditions (i.e., to a rate of 9 pmol/cm2/min) in ciliated cell–
dominant (z90%) primary human airway cultures (19). These
data suggest that ciliated cells are a significant contributor to
ATP release under shear stress.
Our data may have relevance to chronic airway diseases. For
example, increased ATP release and adenosine accumulation
on the surfaces of goblet-cell metaplastic airway epithelia may
be particularly pertinent to asthma pathogenesis. Increased
airway adenosine concentrations are a hallmark of asthma
(35, 36), and increased airway ATP concentrations have been
speculated to play a key role in asthma pathogenesis by acti-
vating dendritic cell functions (37). However, the source for
extracellular airway ATP and adenosine in asthma has been
unclear. Our studies, using IL-13–treated cultures as a model of
asthma-induced goblet cell metaplasia, suggest that metaplastic
goblet cells could represent an important source of ASL nu-
cleotides under stimulated conditions (Figure 5B).
Our data may also be relevant to viral airways infection.
Common acute viral infections (e.g., RSV) produce respiratory
symptoms consistent with mucus hyperproduction and inflam-
mation that may persist for many weeks after initial infection
(38, 39). Data from models that span this time frame (e.g., virus-
infected mice and primary HBE cultures) suggest that this late
postviral phase is associated with goblet cell metaplasia (40, 41).
However, the cellular origins of increased mucus production
and inflammatory signals that produce the postviral syndrome
have not been unambiguously identified. The current study
demonstrated that RSV induces goblet cell metaplasia in HBE
cultures, which not only provides a source of increased mucin
secretion but also increases ASL nucleotides and nucleosides
that may participate in inflammatory signaling (Figures 1 and 2)
(42–50).
In summary, nucleotide release rates increase in parallel to
mucin secretion rates in RSV- and IL-13–induced goblet-cell
metaplastic HBE. The increase in goblet-cell nucleotide release
proportional to increased mucin secretion may provide a com-
pensatory mechanism to hydrate newly secreted mucus and
promote airway surface clearance. In parallel, increased release
into the extracellular environment of adenine nucleotides and
nucleosides may promote airway luminal inflammatory re-
sponses via purinoceptors by stimulating secretion of inflam-
matory mediators from airway epithelia (42–44), secretion of
airway and alveolar fluids (19, 45), mucin gene transcription (43,
46), neutrophil migration (47, 48), and regulating endothelial
barrier function (49, 50). Accordingly, goblet cell–mediated
increases in ATP, adenosine, and UDP-glucose concentrations
in airway lumens may coordinately activate innate host defense
mucociliary clearance and cellular inflammatory pathways.
These compensatory mechanisms are parts of the complex
pathophysiologic scheme pertinent to many chronically dis-
eased airways characterized by goblet cell metaplasia.
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